XML 57 R3.htm IDEA: XBRL DOCUMENT
v3.26.1

Award Timing Disclosure | 12 Months Ended |
--- | --- | ---
Dec. 31, 2025 | May 09, 2025 USD ($) share $ / shares
Award Timing Disclosures [Line Items] |  |
Award Timing MNPI Disclosure | Grants of awards to executive officers under our equity incentive programs are approved by the Committee. Grants are typically made at preestablished Committee meeting dates or in connection with a new hire or promotion, and irrespective of the timing of release of any material nonpublic information. Stock options have an exercise price equal to the NYSE closing market price on the date of grant. Stock option awards are granted to executive officers annually, typically at a regularly scheduled meeting of the Committee. Meeting dates are set in advance, and the timing of the meetings, and the grant of stock options, including terms and value of the awards, is made without regard to any material nonpublic information. The Company has not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. Option Awards Granted in Close Proximity to Disclosure of Material Nonpublic Information In accordance with Item 402(x)(2) of Regulation S‑K, the following table provides information regarding stock option awards granted to our NEOs during the last completed fiscal year within a period beginning four business days before and ending one business day after the filing or furnishing of a Form 10‑Q, Form 10‑K, or Form 8‑K that discloses material nonpublic information (“MNPI”). The Company does not time stock option grants or other equity-based awards to take advantage of the release of MNPI and does not release MNPI for the purpose of affecting the value of executive compensation. On May 9, 2025, as a part of a regularly scheduled meeting, the Compensation and Human Capital Committee approved the annual stock option grant to our NEOs. On May 14, 2025, we filed a Current Report on Form 8‑K (Item 8.01) disclosing that on May 12, 2025 we entered into an underwriting agreement relating to the issuance of multiple series of senior notes (the “Senior Notes Transaction”). Stock options were granted to our NEOs on May 9, 2025, which was within the period described above. The percentage change presented in the table below reflects the change in the closing market price of our class B common stock from the trading day immediately prior to the disclosure of the Senior Notes Transaction to the trading day immediately following such disclosure, as required by Item 402(x)(2). Such grants were not made in contemplation of, nor influenced by, neither the Senior Notes Transaction nor the anticipated disclosure thereof. Each stock option award reflected below was granted with an effective grant date of May 9, 2025 and an exercise price equal to the fair market value of the Company’s class B common stock on the grant date. The options vest at a rate of 20% annually beginning May 9, 2026 and have a 10‑year term. RSUs were also granted to the NEOs (other than the CEO) on May 9, 2025. In accordance with Item 402(x)(2) of Regulation S‑K, the table below reflects only stock options, stock appreciation rights, and similar option‑like instruments.
Name | Grant Date | Number of Securities Underlying the Award (#) | Exercise Price of the Award ($) | Grant Date Fair Value of the Award ($) | Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following the Disclosure of Material Nonpublic Information (%)(1)
Carol Tomé | 5/9/2025 | 72,583 | 95.89 | 1,358,754 | 0.54
Brian Dykes | 5/9/2025 | 22,270 | 95.89 | 416,894 | 0.54
Nando Cesarone | 5/9/2025 | 25,208 | 95.89 | 471,894 | 0.54
Kate Gutmann | 5/9/2025 | 25,208 | 95.89 | 471,894 | 0.54
Bala Subramanian | 5/9/2025 | 21,909 | 95.89 | 410,136 | 0.54
(1)Reflects the change in the closing market price of the Company’s class B common stock from $99.81 on May 13, 2025 (the trading day immediately prior to the disclosure of MNPI) to $100.35 on May 15, 2025 (the trading day immediately following such disclosure), representing an increase of 0.54%. The MNPI was disclosed in the Company’s Current Report on Form 8‑K filed on May 14, 2025, which reported the Company’s entry into an underwriting agreement relating to the issuance of multiple series of senior notes. |
Award Timing Method | Grants are typically made at preestablished Committee meeting dates or in connection with a new hire or promotion, and irrespective of the timing of release of any material nonpublic information. |
Award Timing Predetermined | true |
Award Timing MNPI Considered | true |
Award Timing, How MNPI Considered | Meeting dates are set in advance, and the timing of the meetings, and the grant of stock options, including terms and value of the awards, is made without regard to any material nonpublic information. The Company has not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. Option Awards Granted in Close Proximity to Disclosure of Material Nonpublic Information In accordance with Item 402(x)(2) of Regulation S‑K, the following table provides information regarding stock option awards granted to our NEOs during the last completed fiscal year within a period beginning four business days before and ending one business day after the filing or furnishing of a Form 10‑Q, Form 10‑K, or Form 8‑K that discloses material nonpublic information (“MNPI”). The Company does not time stock option grants or other equity-based awards to take advantage of the release of MNPI and does not release MNPI for the purpose of affecting the value of executive compensation. On May 9, 2025, as a part of a regularly scheduled meeting, the Compensation and Human Capital Committee approved the annual stock option grant to our NEOs. On May 14, 2025, we filed a Current Report on Form 8‑K (Item 8.01) disclosing that on May 12, 2025 we entered into an underwriting agreement relating to the issuance of multiple series of senior notes (the “Senior Notes Transaction”). Stock options were granted to our NEOs on May 9, 2025, which was within the period described above. The percentage change presented in the table below reflects the change in the closing market price of our class B common stock from the trading day immediately prior to the disclosure of the Senior Notes Transaction to the trading day immediately following such disclosure, as required by Item 402(x)(2). Such grants were not made in contemplation of, nor influenced by, neither the Senior Notes Transaction nor the anticipated disclosure thereof. Each stock option award reflected below was granted with an effective grant date of May 9, 2025 and an exercise price equal to the fair market value of the Company’s class B common stock on the grant date. The options vest at a rate of 20% annually beginning May 9, 2026 and have a 10‑year term. RSUs were also granted to the NEOs (other than the CEO) on May 9, 2025. In accordance with Item 402(x)(2) of Regulation S‑K, the table below reflects only stock options, stock appreciation rights, and similar option‑like instruments.
Name | Grant Date | Number of Securities Underlying the Award (#) | Exercise Price of the Award ($) | Grant Date Fair Value of the Award ($) | Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following the Disclosure of Material Nonpublic Information (%)(1)
Carol Tomé | 5/9/2025 | 72,583 | 95.89 | 1,358,754 | 0.54
Brian Dykes | 5/9/2025 | 22,270 | 95.89 | 416,894 | 0.54
Nando Cesarone | 5/9/2025 | 25,208 | 95.89 | 471,894 | 0.54
Kate Gutmann | 5/9/2025 | 25,208 | 95.89 | 471,894 | 0.54
Bala Subramanian | 5/9/2025 | 21,909 | 95.89 | 410,136 | 0.54
(1)Reflects the change in the closing market price of the Company’s class B common stock from $99.81 on May 13, 2025 (the trading day immediately prior to the disclosure of MNPI) to $100.35 on May 15, 2025 (the trading day immediately following such disclosure), representing an increase of 0.54%. The MNPI was disclosed in the Company’s Current Report on Form 8‑K filed on May 14, 2025, which reported the Company’s entry into an underwriting agreement relating to the issuance of multiple series of senior notes. |
MNPI Disclosure Timed for Compensation Value | false |
Awards Close in Time to MNPI Disclosures, Table |
Name | Grant Date | Number of Securities Underlying the Award (#) | Exercise Price of the Award ($) | Grant Date Fair Value of the Award ($) | Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following the Disclosure of Material Nonpublic Information (%)(1)
Carol Tomé | 5/9/2025 | 72,583 | 95.89 | 1,358,754 | 0.54
Brian Dykes | 5/9/2025 | 22,270 | 95.89 | 416,894 | 0.54
Nando Cesarone | 5/9/2025 | 25,208 | 95.89 | 471,894 | 0.54
Kate Gutmann | 5/9/2025 | 25,208 | 95.89 | 471,894 | 0.54
Bala Subramanian | 5/9/2025 | 21,909 | 95.89 | 410,136 | 0.54
(1)Reflects the change in the closing market price of the Company’s class B common stock from $99.81 on May 13, 2025 (the trading day immediately prior to the disclosure of MNPI) to $100.35 on May 15, 2025 (the trading day immediately following such disclosure), representing an increase of 0.54%. The MNPI was disclosed in the Company’s Current Report on Form 8‑K filed on May 14, 2025, which reported the Company’s entry into an underwriting agreement relating to the issuance of multiple series of senior notes. |
Awards Close in Time to MNPI Disclosures |  |
Underlying Security Market Price Change |  | 0.0054
Carol Tomé [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Carol Tomé
Underlying Securities | share |  | 72,583
Exercise Price | $ / shares |  | $ 95.89
Fair Value as of Grant Date | $ |  | $ 1,358,754
Underlying Security Market Price Change |  | 0.0054
Brian Dykes [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Brian Dykes
Underlying Securities | share |  | 22,270
Exercise Price | $ / shares |  | $ 95.89
Fair Value as of Grant Date | $ |  | $ 416,894
Underlying Security Market Price Change |  | 0.0054
Nando Cesarone [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Nando Cesarone
Underlying Securities | share |  | 25,208
Exercise Price | $ / shares |  | $ 95.89
Fair Value as of Grant Date | $ |  | $ 471,894
Underlying Security Market Price Change |  | 0.0054
Kate Gutmann [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Kate Gutmann
Underlying Securities | share |  | 25,208
Exercise Price | $ / shares |  | $ 95.89
Fair Value as of Grant Date | $ |  | $ 471,894
Underlying Security Market Price Change |  | 0.0054
Bala Subramanian [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Bala Subramanian
Underlying Securities | share |  | 21,909
Exercise Price | $ / shares |  | $ 95.89
Fair Value as of Grant Date | $ |  | $ 410,136
Underlying Security Market Price Change |  | 0.0054

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence D + Details
Name: | ecd_AwardExrcPrice
Namespace Prefix: | ecd_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence E + Details
Name: | ecd_AwardGrantDateFairValue
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgDiscLineItems
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgHowMnpiCnsdrdTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgMethodTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgMnpiCnsdrdFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgMnpiDiscTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgPredtrmndFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence C + Details
Name: | ecd_AwardUndrlygSecuritiesAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence A + Details
Name: | ecd_AwardsCloseToMnpiDiscIndName
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 + Details
Name: | ecd_AwardsCloseToMnpiDiscTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 + Details
Name: | ecd_AwardsCloseToMnpiDiscTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_MnpiDiscTimedForCompValFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence F + Details
Name: | ecd_UndrlygSecurityMktPriceChngPct
Namespace Prefix: | ecd_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ecd_IndividualAxis=ups_CarolTomeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=ups_BrianDykesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=ups_NandoCesaroneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=ups_KateGutmannMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=ups_BalaSubramanianMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |